- Cell and gene therapy investment, once booming, is now in a slump https://www.biopharmadive.com/news/cell-gene-therapy-biotech-venture-investment-decline/725401/ 52 comments futurology
- FTC to sue three largest PBMs over drug price practices: WSJ https://www.biopharmadive.com/news/ftc-suit-pharmacy-benefit-managers-caremark-express-scripts-optumrx-wsj/721051/ 2 comments law
- Verve starts first human test of gene editing treatment for heart disease https://www.biopharmadive.com/news/verve-base-editing-first-human-dosing-trial/627042/ 6 comments futurology
- Fourth trial volunteer dies in Astellas gene therapy study https://www.biopharmadive.com/news/astellas-gene-therapy-trial-death-fourth-audentes/606508/ 27 comments science
- Sanofi, in unusual move, to lend spare production capacity to Pfizer, BioNTech, manufacture more than 100 million doses after setbacks and delays in the development of its own vaccine candidates https://www.biopharmadive.com/news/sanofi-in-unusual-move-to-help-pfizer-biontech-make-coronavirus-vaccine/594004/ 98 comments worldnews
- FDA scolds Mylan for 'repeated' manufacturing problems https://www.biopharmadive.com/news/fda-mylan-warning-letter-india-unit-7/584679/ 11 comments business
- Doctors Without Borders blasts $1700 price tag of Otsuka TB drug http://www.biopharmadive.com/news/doctors-without-borders-blasts-1700-price-tag-of-otsuka-tb-drug/414602/ 38 comments worldnews
- Drug testing gone wrong in France is making international news. Just a grim reminder that this is happening on a daily basis in India. http://www.biopharmadive.com/news/warning-letters-reveal-some-of-the-fdas-biggest-problems-with-indian-drugm/412076/ 9 comments india